Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Short-Squeeze Stocks That Could Take Off Before Year-End

By Shane Neagle, InvestorPlace Contributor
These three short-squeeze stocks are seeing high short interest. They each could see a year-end short squeeze and notable market moves.

Why Is Soligenix (SNGX) Stock Up 285% Today?

By William White, InvestorPlace Writer
Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.

Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns

By Yiannis Zourmpanos, InvestorPlace Contributor
Are you looking for income kings with reliable returns? Here are seven blue-chip dividend stocks for reliable returns.

Why Is ImmunoGen (IMGN) Stock Up 81% Today?

By William White, InvestorPlace Writer
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.

Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?

By William White, InvestorPlace Writer
Redhill Biopharma stock is falling on Thursday as shares of RDHL give up some of the gains they made throughout the week.

Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?

By William White, InvestorPlace Writer
Vivos Therapeutics stock is falling on Thursday but that's only after VVOS shares experienced a massive rally on Wednesday!

Why Is Aditxt (ADTX) Stock Up 70% Today?

By William White, InvestorPlace Writer
Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.

Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024

By Omor Ibne Ehsan
Often the best investments are out-of-favor and trade at silly cheap valuations. Check out three such growth stocks with huge upside.

3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years

By Omor Ibne Ehsan
Many stocks now trade at tempting valuations, and these three beaten-down stocks could soar 1,000% within five years.

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally

By Muslim Farooque, InvestorPlace Contributor
explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy

If You Can Only Buy One Cannabis Stock in December, It Better Be One of These 3 Names

By Will Ashworth, InvestorPlace Contributor
Buying cannabis stocks in December has to be a big contrarian play heading into 2024. Here are the three to buy if you must.

Health Insurance Stocks Cigna (CI), Humana (HUM) Eye Merger

By Samuel O'Brient, InvestorPlace Reporter
Cigna and Humana are reportedly on the verge of joining forces in an important deal. Here's why this could be bad news for insurance stocks.

If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names

By Ian Cooper, InvestorPlace Contributor
As we head into December 2023, some of the hottest investment opportunities can be found in these biotech stocks.

Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today?

By William White, InvestorPlace Writer
Vivos Therapeutics stock is rocketing higher on Wednesday with heavy trading of VVOS shares following approval from the FDA!

Why Is BioVie (BIVI) Stock Down 63% Today?

By William White, InvestorPlace Writer
BioVie stock is falling after its Phase 3 clinical trial of its Alzheimer’s treatment candidate failed to show statistical significance.

Why Is Seelos Therapeutics (SEEL) Stock Down 42% Today?

By William White, InvestorPlace Writer
Seelos Therapeutics stock is falling on Wednesday after the company announced and priced a public offering for shares of SEEL.

Why Is Avenue Therapeutics (ATXI) Stock Up 59% Today?

By William White, InvestorPlace Writer
Avenue Therapeutics stock is rising higher on Wednesday following news of an investor taking a 14.5% stake in ATXI shares.

3 Top-Rated Cannabis Stocks That Analysts Are Loving Now

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Since the legalization of cannabis is grabbing the market by storm, it's best to jump in now with these winning stocks.

3 Healthcare Stocks to Pick Up Before the Year-End Rally

By Muslim Farooque, InvestorPlace Contributor
Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending
Load More Articles